The Joan and Sanford I. Weill Center for Metabolic Health brings together scientists and clinicians across Weill Cornell Medicine and our Tri-I partners to advance the understanding of diabetes, obesity, and other metabolic diseases. Our mission is to drive breakthrough discoveries and develop new therapeutics. Directed by Dr. Laura Alonso, our investigators leverage stem cells, cellular and molecular biology, genetics, proteomics, and nutritional research to uncover the molecular mechanisms of these critical conditions. The Metabolic Phenotyping Center conducts sophisticated metabolic studies in rodent models and delivers the highest-quality assays of blood markers.
Our work is at the forefront of advances in metabolic health, including research on the biology and therapeutic use of GLP-1/GIP agonists to manage diabetes and obesity. We unite faculty across institutions to catalyze transformational team science and collaborative growth, fostering faculty and trainees to address pressing real-world challenges in metabolic health. We are proud to support 47 faculty members (20 PhDs, 18 MDs, and 7 MD-PhDs). Meet our members.
